Keros Therapeutics, Inc. ($KROS)
Filing Information
| Accession Number | 0001221590-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 11, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
2,000
Total Value
$22,420.00
P&L
-1.7% ($389.20)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 9, 2026 | Purchase | 2,000 | $11.21 | $22,420.00 | 7,450 | Direct | โ | View Details |